A groundbreaking study led by researchers at The Ohio State University has introduced a novel and highly efficient method for…
Read More
Eli Lilly Acquires Engage Biologics for Up to $202 Million, Bolstering Its Genetic Medicine Pipeline with Innovative Non-Viral DNA Delivery Technology
Pharmaceutical giant Eli Lilly and Company has announced its agreement to acquire Engage Biologics, a California-based biotechnology firm, for a…
Read More
The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising Alternatives
Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More
Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development
A pioneering scientific breakthrough has emerged from Scripps Research in California, USA, in collaboration with IAVI (New York, USA) and…
Read More
